GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis

Ricardo A. Cordova(Indiana University Health), Kirk A. Staschke(Indiana University School of Medicine)
bioRxiv (Cold Spring Harbor Laboratory)
June 18, 2022
10.1101/2022.06.17.496598
Cited by 4

Related Papers

IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated Disease
|The Journal of Immunology|2009|54
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors
|Clinical Cancer Research|2023|27
Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer
|Science Signaling|2024|9
Abstract 6231: Activation of GCN2 by HC-7366 results in significant antitumor efficacy as monotherapy and in combination with multiple standard of care agents in various solid cancer models
|Cancer Research|2023|3
Activation of GCN2 By HC-7366 Results in Significant Anti-Tumor Efficacy As Monotherapy and Overcomes Resistance Mechanisms When Combined with Venetoclax in AML
|Blood|2023|3